Description: About UsSagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase FASN inhibitors that are designed to target dysfunctional metabolic pathways in diseases resulting (more...) Company: Sagimet Biosciences Location: San Mateo Posted on: 1970-01-01